Clinical Trial Update: Interaction Study SLV337/Simvastatin [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the interaction between SLV337 and simvastatin has been completed in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• SLV337

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED